Dataset | Score | p-value 1 | p-value 2 | p-value 3 |
---|---|---|---|---|
chia-screen-data-Fav | 2.825 | 2.15e-15 | 5.49e-04 | 3.70e-03 |
Gene Symbol | Entrez Gene ID | Frequency | chia-screen-data-Fav gene score | Best subnetwork score | Degree | Chia-Hits Primary | Chia-Hits Secondary |
---|---|---|---|---|---|---|---|
RHOA | 387 | 5 | -2.408 | 2.845 | 151 | Yes | Yes |
ZC3H18 | 124245 | 3 | -2.426 | 2.937 | 6 | Yes | - |
YAP1 | 10413 | 94 | -4.256 | 3.538 | 53 | Yes | - |
POU5F1 | 5460 | 133 | -5.148 | 3.538 | 179 | Yes | Yes |
SON | 6651 | 9 | -3.844 | 3.108 | 9 | Yes | Yes |
[ KTN1 ] | 3895 | 1 | -1.212 | 2.825 | 18 | - | - |
SUMO1 | 7341 | 7 | -1.696 | 3.050 | 439 | - | - |
TPR | 7175 | 18 | -2.638 | 3.072 | 28 | Yes | Yes |
APLP2 | 334 | 12 | -2.732 | 3.206 | 35 | Yes | Yes |
PSMD2 | 5708 | 47 | -4.172 | 3.157 | 386 | Yes | Yes |
CDC42 | 998 | 9 | -2.199 | 3.119 | 265 | Yes | Yes |
SHFM1 | 7979 | 2 | -2.366 | 2.847 | 6 | Yes | - |
TBC1D10A | 83874 | 8 | -2.544 | 2.989 | 26 | Yes | - |
MED12 | 9968 | 14 | -2.465 | 3.206 | 65 | Yes | - |
HNRNPU | 3192 | 76 | -2.869 | 3.538 | 139 | Yes | - |
ACSS1 | 84532 | 2 | -2.326 | 2.842 | 148 | Yes | - |
CDK12 | 51755 | 6 | -2.714 | 2.944 | 15 | Yes | - |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
HNRNPU | 3192 | SUMO1 | 7341 | pp | -- | int.I2D: BioGrid |
SON | 6651 | SUMO1 | 7341 | pp | -- | int.I2D: BioGrid |
APLP2 | 334 | MED12 | 9968 | pp | -- | int.I2D: MINT; int.Mint: MI:0407(direct interaction) |
SUMO1 | 7341 | MED12 | 9968 | pp | -- | int.I2D: BioGrid |
RHOA | 387 | ACSS1 | 84532 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, MINT_Yeast, YeastLow |
HNRNPU | 3192 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
SUMO1 | 7341 | ZC3H18 | 124245 | pp | -- | int.I2D: BioGrid |
KTN1 | 3895 | SUMO1 | 7341 | pp | -- | int.I2D: BioGrid |
PSMD2 | 5708 | ACSS1 | 84532 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
SUMO1 | 7341 | CDK12 | 51755 | pp | -- | int.I2D: BioGrid |
HNRNPU | 3192 | YAP1 | 10413 | pp | -- | int.I2D: HPRD; int.HPRD: in vitro, in vivo |
CDC42 | 998 | SHFM1 | 7979 | pp | -- | int.I2D: IntAct, SOURAV_MAPK_LOW |
RHOA | 387 | TBC1D10A | 83874 | pp | -- | int.I2D: BioGrid_Yeast |
RHOA | 387 | PSMD2 | 5708 | pp | -- | int.I2D: BioGrid_Yeast |
CDC42 | 998 | TBC1D10A | 83874 | pp | -- | int.I2D: BioGrid_Yeast |
RHOA | 387 | KTN1 | 3895 | pp | -- | int.I2D: BioGrid, HPRD; int.HPRD: in vitro, in vivo, yeast 2-hybrid |
APLP2 | 334 | RHOA | 387 | pp | -- | int.I2D: IntAct_Mouse |
POU5F1 | 5460 | SUMO1 | 7341 | pp | -- | int.I2D: BioGrid, BioGrid_Mouse |
CDC42 | 998 | KTN1 | 3895 | pp | -- | int.I2D: HPRD; int.HPRD: in vitro, yeast 2-hybrid |
TPR | 7175 | SUMO1 | 7341 | pp | -- | int.I2D: BioGrid |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0005515 | protein binding | 1.03e-04 | 1.00e+00 | 1.079 | 15 | 198 | 6024 |
GO:0044822 | poly(A) RNA binding | 1.12e-04 | 1.00e+00 | 2.492 | 7 | 50 | 1056 |
GO:0005654 | nucleoplasm | 1.31e-04 | 1.00e+00 | 2.456 | 7 | 64 | 1082 |
GO:0042176 | regulation of protein catabolic process | 1.55e-04 | 1.00e+00 | 6.729 | 2 | 2 | 16 |
GO:0090316 | positive regulation of intracellular protein transport | 1.76e-04 | 1.00e+00 | 6.641 | 2 | 2 | 17 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 2.98e-04 | 1.00e+00 | 6.269 | 2 | 2 | 22 |
GO:0032467 | positive regulation of cytokinesis | 4.51e-04 | 1.00e+00 | 5.974 | 2 | 2 | 27 |
GO:0072686 | mitotic spindle | 5.21e-04 | 1.00e+00 | 5.871 | 2 | 3 | 29 |
GO:0031647 | regulation of protein stability | 5.58e-04 | 1.00e+00 | 5.822 | 2 | 4 | 30 |
GO:0016607 | nuclear speck | 1.00e-03 | 1.00e+00 | 3.887 | 3 | 12 | 172 |
GO:1901673 | regulation of spindle assembly involved in mitosis | 1.18e-03 | 1.00e+00 | 9.729 | 1 | 1 | 1 |
GO:0043578 | nuclear matrix organization | 1.18e-03 | 1.00e+00 | 9.729 | 1 | 1 | 1 |
GO:0010965 | regulation of mitotic sister chromatid separation | 1.18e-03 | 1.00e+00 | 9.729 | 1 | 1 | 1 |
GO:0006404 | RNA import into nucleus | 1.18e-03 | 1.00e+00 | 9.729 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 1.18e-03 | 1.00e+00 | 9.729 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 1.18e-03 | 1.00e+00 | 9.729 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 1.18e-03 | 1.00e+00 | 9.729 | 1 | 1 | 1 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 1.18e-03 | 1.00e+00 | 9.729 | 1 | 1 | 1 |
GO:0061383 | trabecula morphogenesis | 1.18e-03 | 1.00e+00 | 9.729 | 1 | 1 | 1 |
GO:0006085 | acetyl-CoA biosynthetic process | 1.18e-03 | 1.00e+00 | 9.729 | 1 | 1 | 1 |
GO:0031453 | positive regulation of heterochromatin assembly | 1.18e-03 | 1.00e+00 | 9.729 | 1 | 1 | 1 |
GO:0021762 | substantia nigra development | 1.20e-03 | 1.00e+00 | 5.269 | 2 | 4 | 44 |
GO:0005643 | nuclear pore | 2.01e-03 | 1.00e+00 | 4.896 | 2 | 11 | 57 |
GO:0000502 | proteasome complex | 2.08e-03 | 1.00e+00 | 4.871 | 2 | 3 | 58 |
GO:0008380 | RNA splicing | 2.25e-03 | 1.00e+00 | 3.481 | 3 | 22 | 228 |
GO:0071338 | positive regulation of hair follicle cell proliferation | 2.36e-03 | 1.00e+00 | 8.729 | 1 | 1 | 2 |
GO:0060242 | contact inhibition | 2.36e-03 | 1.00e+00 | 8.729 | 1 | 1 | 2 |
GO:0031990 | mRNA export from nucleus in response to heat stress | 2.36e-03 | 1.00e+00 | 8.729 | 1 | 2 | 2 |
GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain | 2.36e-03 | 1.00e+00 | 8.729 | 1 | 1 | 2 |
GO:0090204 | protein localization to nuclear pore | 2.36e-03 | 1.00e+00 | 8.729 | 1 | 1 | 2 |
GO:0009786 | regulation of asymmetric cell division | 2.36e-03 | 1.00e+00 | 8.729 | 1 | 1 | 2 |
GO:0070840 | dynein complex binding | 2.36e-03 | 1.00e+00 | 8.729 | 1 | 1 | 2 |
GO:0019427 | acetyl-CoA biosynthetic process from acetate | 2.36e-03 | 1.00e+00 | 8.729 | 1 | 1 | 2 |
GO:0019413 | acetate biosynthetic process | 2.36e-03 | 1.00e+00 | 8.729 | 1 | 1 | 2 |
GO:0060661 | submandibular salivary gland formation | 2.36e-03 | 1.00e+00 | 8.729 | 1 | 1 | 2 |
GO:0046832 | negative regulation of RNA export from nucleus | 2.36e-03 | 1.00e+00 | 8.729 | 1 | 1 | 2 |
GO:0000189 | MAPK import into nucleus | 2.36e-03 | 1.00e+00 | 8.729 | 1 | 1 | 2 |
GO:0019542 | propionate biosynthetic process | 2.36e-03 | 1.00e+00 | 8.729 | 1 | 1 | 2 |
GO:0090135 | actin filament branching | 2.36e-03 | 1.00e+00 | 8.729 | 1 | 1 | 2 |
GO:0002944 | cyclin K-CDK12 complex | 2.36e-03 | 1.00e+00 | 8.729 | 1 | 1 | 2 |
GO:0060070 | canonical Wnt signaling pathway | 3.45e-03 | 1.00e+00 | 4.500 | 2 | 4 | 75 |
GO:0051683 | establishment of Golgi localization | 3.53e-03 | 1.00e+00 | 8.144 | 1 | 1 | 3 |
GO:0034191 | apolipoprotein A-I receptor binding | 3.53e-03 | 1.00e+00 | 8.144 | 1 | 1 | 3 |
GO:0046914 | transition metal ion binding | 3.53e-03 | 1.00e+00 | 8.144 | 1 | 1 | 3 |
GO:0003987 | acetate-CoA ligase activity | 3.53e-03 | 1.00e+00 | 8.144 | 1 | 1 | 3 |
GO:0042306 | regulation of protein import into nucleus | 3.53e-03 | 1.00e+00 | 8.144 | 1 | 2 | 3 |
GO:0060913 | cardiac cell fate determination | 3.53e-03 | 1.00e+00 | 8.144 | 1 | 1 | 3 |
GO:0001650 | fibrillar center | 3.53e-03 | 1.00e+00 | 8.144 | 1 | 1 | 3 |
GO:0003161 | cardiac conduction system development | 3.53e-03 | 1.00e+00 | 8.144 | 1 | 1 | 3 |
GO:0090245 | axis elongation involved in somitogenesis | 3.53e-03 | 1.00e+00 | 8.144 | 1 | 1 | 3 |
GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex | 3.53e-03 | 1.00e+00 | 8.144 | 1 | 1 | 3 |
GO:0006405 | RNA export from nucleus | 3.53e-03 | 1.00e+00 | 8.144 | 1 | 2 | 3 |
GO:0033688 | regulation of osteoblast proliferation | 3.53e-03 | 1.00e+00 | 8.144 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 3.53e-03 | 1.00e+00 | 8.144 | 1 | 1 | 3 |
GO:0014044 | Schwann cell development | 4.71e-03 | 1.00e+00 | 7.729 | 1 | 1 | 4 |
GO:0038027 | apolipoprotein A-I-mediated signaling pathway | 4.71e-03 | 1.00e+00 | 7.729 | 1 | 1 | 4 |
GO:0030578 | PML body organization | 4.71e-03 | 1.00e+00 | 7.729 | 1 | 1 | 4 |
GO:0048664 | neuron fate determination | 4.71e-03 | 1.00e+00 | 7.729 | 1 | 1 | 4 |
GO:0060684 | epithelial-mesenchymal cell signaling | 4.71e-03 | 1.00e+00 | 7.729 | 1 | 1 | 4 |
GO:0051835 | positive regulation of synapse structural plasticity | 4.71e-03 | 1.00e+00 | 7.729 | 1 | 1 | 4 |
GO:0006999 | nuclear pore organization | 4.71e-03 | 1.00e+00 | 7.729 | 1 | 1 | 4 |
GO:0072384 | organelle transport along microtubule | 4.71e-03 | 1.00e+00 | 7.729 | 1 | 1 | 4 |
GO:0044615 | nuclear pore nuclear basket | 4.71e-03 | 1.00e+00 | 7.729 | 1 | 1 | 4 |
GO:0051726 | regulation of cell cycle | 5.70e-03 | 1.00e+00 | 4.129 | 2 | 5 | 97 |
GO:0001714 | endodermal cell fate specification | 5.88e-03 | 1.00e+00 | 7.407 | 1 | 1 | 5 |
GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint | 5.88e-03 | 1.00e+00 | 7.407 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 5.88e-03 | 1.00e+00 | 7.407 | 1 | 2 | 5 |
GO:0036336 | dendritic cell migration | 5.88e-03 | 1.00e+00 | 7.407 | 1 | 1 | 5 |
GO:0035088 | establishment or maintenance of apical/basal cell polarity | 5.88e-03 | 1.00e+00 | 7.407 | 1 | 1 | 5 |
GO:0031256 | leading edge membrane | 5.88e-03 | 1.00e+00 | 7.407 | 1 | 1 | 5 |
GO:0010793 | regulation of mRNA export from nucleus | 5.88e-03 | 1.00e+00 | 7.407 | 1 | 1 | 5 |
GO:0043405 | regulation of MAP kinase activity | 5.88e-03 | 1.00e+00 | 7.407 | 1 | 1 | 5 |
GO:0070849 | response to epidermal growth factor | 5.88e-03 | 1.00e+00 | 7.407 | 1 | 1 | 5 |
GO:0007176 | regulation of epidermal growth factor-activated receptor activity | 5.88e-03 | 1.00e+00 | 7.407 | 1 | 1 | 5 |
GO:0010467 | gene expression | 6.73e-03 | 1.00e+00 | 2.343 | 4 | 45 | 669 |
GO:0030496 | midbody | 7.02e-03 | 1.00e+00 | 3.974 | 2 | 2 | 108 |
GO:0007097 | nuclear migration | 7.05e-03 | 1.00e+00 | 7.144 | 1 | 1 | 6 |
GO:0003334 | keratinocyte development | 7.05e-03 | 1.00e+00 | 7.144 | 1 | 1 | 6 |
GO:0036089 | cleavage furrow formation | 7.05e-03 | 1.00e+00 | 7.144 | 1 | 2 | 6 |
GO:0050733 | RS domain binding | 7.05e-03 | 1.00e+00 | 7.144 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 7.05e-03 | 1.00e+00 | 7.144 | 1 | 3 | 6 |
GO:0060789 | hair follicle placode formation | 7.05e-03 | 1.00e+00 | 7.144 | 1 | 2 | 6 |
GO:0048554 | positive regulation of metalloenzyme activity | 7.05e-03 | 1.00e+00 | 7.144 | 1 | 1 | 6 |
GO:0043497 | regulation of protein heterodimerization activity | 7.05e-03 | 1.00e+00 | 7.144 | 1 | 1 | 6 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 7.93e-03 | 1.00e+00 | 3.883 | 2 | 3 | 115 |
GO:0046825 | regulation of protein export from nucleus | 8.22e-03 | 1.00e+00 | 6.921 | 1 | 2 | 7 |
GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 8.22e-03 | 1.00e+00 | 6.921 | 1 | 2 | 7 |
GO:0043931 | ossification involved in bone maturation | 8.22e-03 | 1.00e+00 | 6.921 | 1 | 1 | 7 |
GO:0051489 | regulation of filopodium assembly | 8.22e-03 | 1.00e+00 | 6.921 | 1 | 1 | 7 |
GO:0043297 | apical junction assembly | 8.22e-03 | 1.00e+00 | 6.921 | 1 | 1 | 7 |
GO:0030036 | actin cytoskeleton organization | 9.02e-03 | 1.00e+00 | 3.786 | 2 | 3 | 123 |
GO:0097202 | activation of cysteine-type endopeptidase activity | 9.39e-03 | 1.00e+00 | 6.729 | 1 | 1 | 8 |
GO:0051292 | nuclear pore complex assembly | 9.39e-03 | 1.00e+00 | 6.729 | 1 | 4 | 8 |
GO:0007617 | mating behavior | 9.39e-03 | 1.00e+00 | 6.729 | 1 | 1 | 8 |
GO:0035457 | cellular response to interferon-alpha | 9.39e-03 | 1.00e+00 | 6.729 | 1 | 1 | 8 |
GO:0016020 | membrane | 9.85e-03 | 1.00e+00 | 1.598 | 6 | 46 | 1681 |
GO:0042405 | nuclear inclusion body | 1.06e-02 | 1.00e+00 | 6.559 | 1 | 2 | 9 |
GO:0016208 | AMP binding | 1.06e-02 | 1.00e+00 | 6.559 | 1 | 1 | 9 |
GO:0090136 | epithelial cell-cell adhesion | 1.06e-02 | 1.00e+00 | 6.559 | 1 | 1 | 9 |
GO:0043495 | protein anchor | 1.06e-02 | 1.00e+00 | 6.559 | 1 | 1 | 9 |
GO:0043296 | apical junction complex | 1.06e-02 | 1.00e+00 | 6.559 | 1 | 1 | 9 |
GO:0031274 | positive regulation of pseudopodium assembly | 1.17e-02 | 1.00e+00 | 6.407 | 1 | 2 | 10 |
GO:0060071 | Wnt signaling pathway, planar cell polarity pathway | 1.17e-02 | 1.00e+00 | 6.407 | 1 | 1 | 10 |
GO:0090307 | spindle assembly involved in mitosis | 1.17e-02 | 1.00e+00 | 6.407 | 1 | 1 | 10 |
GO:0035413 | positive regulation of catenin import into nucleus | 1.17e-02 | 1.00e+00 | 6.407 | 1 | 2 | 10 |
GO:0006069 | ethanol oxidation | 1.17e-02 | 1.00e+00 | 6.407 | 1 | 1 | 10 |
GO:0060047 | heart contraction | 1.17e-02 | 1.00e+00 | 6.407 | 1 | 1 | 10 |
GO:0019789 | SUMO ligase activity | 1.29e-02 | 1.00e+00 | 6.269 | 1 | 1 | 11 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 1.29e-02 | 1.00e+00 | 6.269 | 1 | 4 | 11 |
GO:0006878 | cellular copper ion homeostasis | 1.41e-02 | 1.00e+00 | 6.144 | 1 | 1 | 12 |
GO:0045947 | negative regulation of translational initiation | 1.41e-02 | 1.00e+00 | 6.144 | 1 | 2 | 12 |
GO:0034399 | nuclear periphery | 1.41e-02 | 1.00e+00 | 6.144 | 1 | 5 | 12 |
GO:0005838 | proteasome regulatory particle | 1.41e-02 | 1.00e+00 | 6.144 | 1 | 1 | 12 |
GO:0035198 | miRNA binding | 1.41e-02 | 1.00e+00 | 6.144 | 1 | 1 | 12 |
GO:0006397 | mRNA processing | 1.49e-02 | 1.00e+00 | 3.407 | 2 | 10 | 160 |
GO:0071480 | cellular response to gamma radiation | 1.52e-02 | 1.00e+00 | 6.028 | 1 | 1 | 13 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 1.52e-02 | 1.00e+00 | 6.028 | 1 | 2 | 13 |
GO:0051019 | mitogen-activated protein kinase binding | 1.52e-02 | 1.00e+00 | 6.028 | 1 | 2 | 13 |
GO:0031334 | positive regulation of protein complex assembly | 1.52e-02 | 1.00e+00 | 6.028 | 1 | 2 | 13 |
GO:0032039 | integrator complex | 1.52e-02 | 1.00e+00 | 6.028 | 1 | 1 | 13 |
GO:0005868 | cytoplasmic dynein complex | 1.52e-02 | 1.00e+00 | 6.028 | 1 | 1 | 13 |
GO:0030234 | enzyme regulator activity | 1.52e-02 | 1.00e+00 | 6.028 | 1 | 2 | 13 |
GO:0046827 | positive regulation of protein export from nucleus | 1.52e-02 | 1.00e+00 | 6.028 | 1 | 1 | 13 |
GO:0001967 | suckling behavior | 1.64e-02 | 1.00e+00 | 5.921 | 1 | 1 | 14 |
GO:0030518 | intracellular steroid hormone receptor signaling pathway | 1.64e-02 | 1.00e+00 | 5.921 | 1 | 6 | 14 |
GO:0031333 | negative regulation of protein complex assembly | 1.64e-02 | 1.00e+00 | 5.921 | 1 | 1 | 14 |
GO:0031996 | thioesterase binding | 1.64e-02 | 1.00e+00 | 5.921 | 1 | 1 | 14 |
GO:0031965 | nuclear membrane | 1.64e-02 | 1.00e+00 | 3.336 | 2 | 10 | 168 |
GO:0044212 | transcription regulatory region DNA binding | 1.64e-02 | 1.00e+00 | 3.336 | 2 | 17 | 168 |
GO:0005487 | nucleocytoplasmic transporter activity | 1.64e-02 | 1.00e+00 | 5.921 | 1 | 3 | 14 |
GO:0042809 | vitamin D receptor binding | 1.75e-02 | 1.00e+00 | 5.822 | 1 | 6 | 15 |
GO:0042307 | positive regulation of protein import into nucleus | 1.75e-02 | 1.00e+00 | 5.822 | 1 | 4 | 15 |
GO:0030225 | macrophage differentiation | 1.75e-02 | 1.00e+00 | 5.822 | 1 | 2 | 15 |
GO:0001824 | blastocyst development | 1.75e-02 | 1.00e+00 | 5.822 | 1 | 2 | 15 |
GO:0051233 | spindle midzone | 1.75e-02 | 1.00e+00 | 5.822 | 1 | 2 | 15 |
GO:0031625 | ubiquitin protein ligase binding | 1.82e-02 | 1.00e+00 | 3.253 | 2 | 5 | 178 |
GO:0005634 | nucleus | 1.86e-02 | 1.00e+00 | 0.896 | 10 | 159 | 4559 |
GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity | 1.87e-02 | 1.00e+00 | 5.729 | 1 | 1 | 16 |
GO:0060334 | regulation of interferon-gamma-mediated signaling pathway | 1.87e-02 | 1.00e+00 | 5.729 | 1 | 1 | 16 |
GO:0001190 | RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription | 1.87e-02 | 1.00e+00 | 5.729 | 1 | 2 | 16 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.94e-02 | 1.00e+00 | 3.205 | 2 | 22 | 184 |
GO:0050919 | negative chemotaxis | 1.99e-02 | 1.00e+00 | 5.641 | 1 | 1 | 17 |
GO:0017022 | myosin binding | 1.99e-02 | 1.00e+00 | 5.641 | 1 | 2 | 17 |
GO:0030742 | GTP-dependent protein binding | 1.99e-02 | 1.00e+00 | 5.641 | 1 | 1 | 17 |
GO:0022624 | proteasome accessory complex | 1.99e-02 | 1.00e+00 | 5.641 | 1 | 1 | 17 |
GO:0030332 | cyclin binding | 2.10e-02 | 1.00e+00 | 5.559 | 1 | 1 | 18 |
GO:0050772 | positive regulation of axonogenesis | 2.10e-02 | 1.00e+00 | 5.559 | 1 | 1 | 18 |
GO:0007088 | regulation of mitosis | 2.10e-02 | 1.00e+00 | 5.559 | 1 | 1 | 18 |
GO:0042346 | positive regulation of NF-kappaB import into nucleus | 2.10e-02 | 1.00e+00 | 5.559 | 1 | 1 | 18 |
GO:0003924 | GTPase activity | 2.21e-02 | 1.00e+00 | 3.107 | 2 | 7 | 197 |
GO:0046847 | filopodium assembly | 2.22e-02 | 1.00e+00 | 5.481 | 1 | 1 | 19 |
GO:0050771 | negative regulation of axonogenesis | 2.33e-02 | 1.00e+00 | 5.407 | 1 | 1 | 20 |
GO:0016032 | viral process | 2.33e-02 | 1.00e+00 | 2.253 | 3 | 26 | 534 |
GO:0014003 | oligodendrocyte development | 2.33e-02 | 1.00e+00 | 5.407 | 1 | 5 | 20 |
GO:0043393 | regulation of protein binding | 2.33e-02 | 1.00e+00 | 5.407 | 1 | 1 | 20 |
GO:0031435 | mitogen-activated protein kinase kinase kinase binding | 2.45e-02 | 1.00e+00 | 5.336 | 1 | 1 | 21 |
GO:0045862 | positive regulation of proteolysis | 2.45e-02 | 1.00e+00 | 5.336 | 1 | 2 | 21 |
GO:0031424 | keratinization | 2.56e-02 | 1.00e+00 | 5.269 | 1 | 1 | 22 |
GO:0043484 | regulation of RNA splicing | 2.56e-02 | 1.00e+00 | 5.269 | 1 | 1 | 22 |
GO:0006184 | GTP catabolic process | 2.57e-02 | 1.00e+00 | 2.987 | 2 | 7 | 214 |
GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading | 2.68e-02 | 1.00e+00 | 5.205 | 1 | 3 | 23 |
GO:0002040 | sprouting angiogenesis | 2.68e-02 | 1.00e+00 | 5.205 | 1 | 2 | 23 |
GO:0051017 | actin filament bundle assembly | 2.68e-02 | 1.00e+00 | 5.205 | 1 | 1 | 23 |
GO:0019221 | cytokine-mediated signaling pathway | 2.73e-02 | 1.00e+00 | 2.941 | 2 | 8 | 221 |
GO:0007163 | establishment or maintenance of cell polarity | 2.79e-02 | 1.00e+00 | 5.144 | 1 | 2 | 24 |
GO:1902017 | regulation of cilium assembly | 2.79e-02 | 1.00e+00 | 5.144 | 1 | 2 | 24 |
GO:0006611 | protein export from nucleus | 2.91e-02 | 1.00e+00 | 5.085 | 1 | 3 | 25 |
GO:0016925 | protein sumoylation | 2.91e-02 | 1.00e+00 | 5.085 | 1 | 2 | 25 |
GO:0035329 | hippo signaling | 3.02e-02 | 1.00e+00 | 5.028 | 1 | 5 | 26 |
GO:0043392 | negative regulation of DNA binding | 3.02e-02 | 1.00e+00 | 5.028 | 1 | 4 | 26 |
GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 3.02e-02 | 1.00e+00 | 5.028 | 1 | 3 | 26 |
GO:0050770 | regulation of axonogenesis | 3.02e-02 | 1.00e+00 | 5.028 | 1 | 2 | 26 |
GO:0046966 | thyroid hormone receptor binding | 3.02e-02 | 1.00e+00 | 5.028 | 1 | 6 | 26 |
GO:0045859 | regulation of protein kinase activity | 3.02e-02 | 1.00e+00 | 5.028 | 1 | 1 | 26 |
GO:0003713 | transcription coactivator activity | 3.11e-02 | 1.00e+00 | 2.840 | 2 | 24 | 237 |
GO:0015631 | tubulin binding | 3.14e-02 | 1.00e+00 | 4.974 | 1 | 2 | 27 |
GO:0051149 | positive regulation of muscle cell differentiation | 3.14e-02 | 1.00e+00 | 4.974 | 1 | 4 | 27 |
GO:0031069 | hair follicle morphogenesis | 3.14e-02 | 1.00e+00 | 4.974 | 1 | 1 | 27 |
GO:0008134 | transcription factor binding | 3.23e-02 | 1.00e+00 | 2.810 | 2 | 18 | 242 |
GO:0034605 | cellular response to heat | 3.25e-02 | 1.00e+00 | 4.921 | 1 | 1 | 28 |
GO:0019894 | kinesin binding | 3.25e-02 | 1.00e+00 | 4.921 | 1 | 1 | 28 |
GO:0030901 | midbrain development | 3.37e-02 | 1.00e+00 | 4.871 | 1 | 1 | 29 |
GO:0006606 | protein import into nucleus | 3.48e-02 | 1.00e+00 | 4.822 | 1 | 2 | 30 |
GO:0010827 | regulation of glucose transport | 3.48e-02 | 1.00e+00 | 4.822 | 1 | 4 | 30 |
GO:0004693 | cyclin-dependent protein serine/threonine kinase activity | 3.59e-02 | 1.00e+00 | 4.774 | 1 | 1 | 31 |
GO:0007094 | mitotic spindle assembly checkpoint | 3.59e-02 | 1.00e+00 | 4.774 | 1 | 3 | 31 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 3.71e-02 | 1.00e+00 | 4.729 | 1 | 2 | 32 |
GO:0031072 | heat shock protein binding | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 2 | 33 |
GO:0001104 | RNA polymerase II transcription cofactor activity | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 8 | 33 |
GO:0005097 | Rab GTPase activator activity | 3.93e-02 | 1.00e+00 | 4.641 | 1 | 1 | 34 |
GO:0042692 | muscle cell differentiation | 3.93e-02 | 1.00e+00 | 4.641 | 1 | 4 | 34 |
GO:0016592 | mediator complex | 4.05e-02 | 1.00e+00 | 4.599 | 1 | 10 | 35 |
GO:0030178 | negative regulation of Wnt signaling pathway | 4.05e-02 | 1.00e+00 | 4.599 | 1 | 4 | 35 |
GO:0034332 | adherens junction organization | 4.16e-02 | 1.00e+00 | 4.559 | 1 | 2 | 36 |
GO:0007077 | mitotic nuclear envelope disassembly | 4.16e-02 | 1.00e+00 | 4.559 | 1 | 4 | 36 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 4.16e-02 | 1.00e+00 | 4.559 | 1 | 2 | 36 |
GO:0045740 | positive regulation of DNA replication | 4.16e-02 | 1.00e+00 | 4.559 | 1 | 1 | 36 |
GO:0007264 | small GTPase mediated signal transduction | 4.19e-02 | 1.00e+00 | 2.604 | 2 | 3 | 279 |
GO:0032880 | regulation of protein localization | 4.28e-02 | 1.00e+00 | 4.519 | 1 | 2 | 37 |
GO:0005902 | microvillus | 4.39e-02 | 1.00e+00 | 4.481 | 1 | 3 | 38 |
GO:0051496 | positive regulation of stress fiber assembly | 4.39e-02 | 1.00e+00 | 4.481 | 1 | 4 | 38 |
GO:0032154 | cleavage furrow | 4.39e-02 | 1.00e+00 | 4.481 | 1 | 1 | 38 |
GO:0008645 | hexose transport | 4.50e-02 | 1.00e+00 | 4.443 | 1 | 4 | 39 |
GO:0035019 | somatic stem cell maintenance | 4.61e-02 | 1.00e+00 | 4.407 | 1 | 6 | 40 |
GO:0050885 | neuromuscular process controlling balance | 4.61e-02 | 1.00e+00 | 4.407 | 1 | 2 | 40 |
GO:0042147 | retrograde transport, endosome to Golgi | 4.73e-02 | 1.00e+00 | 4.371 | 1 | 1 | 41 |
GO:0030521 | androgen receptor signaling pathway | 4.73e-02 | 1.00e+00 | 4.371 | 1 | 5 | 41 |
GO:0019898 | extrinsic component of membrane | 4.84e-02 | 1.00e+00 | 4.336 | 1 | 2 | 42 |
GO:0003677 | DNA binding | 4.95e-02 | 1.00e+00 | 1.478 | 4 | 49 | 1218 |
GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity | 4.95e-02 | 1.00e+00 | 4.302 | 1 | 7 | 43 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 5.06e-02 | 1.00e+00 | 4.269 | 1 | 3 | 44 |
GO:0034613 | cellular protein localization | 5.06e-02 | 1.00e+00 | 4.269 | 1 | 2 | 44 |
GO:0003712 | transcription cofactor activity | 5.06e-02 | 1.00e+00 | 4.269 | 1 | 8 | 44 |
GO:0005525 | GTP binding | 5.06e-02 | 1.00e+00 | 2.452 | 2 | 12 | 310 |
GO:0043525 | positive regulation of neuron apoptotic process | 5.29e-02 | 1.00e+00 | 4.205 | 1 | 4 | 46 |
GO:0007411 | axon guidance | 5.33e-02 | 1.00e+00 | 2.411 | 2 | 5 | 319 |
GO:0007266 | Rho protein signal transduction | 5.40e-02 | 1.00e+00 | 4.174 | 1 | 1 | 47 |
GO:0019827 | stem cell maintenance | 5.40e-02 | 1.00e+00 | 4.174 | 1 | 7 | 47 |
GO:0003682 | chromatin binding | 5.57e-02 | 1.00e+00 | 2.375 | 2 | 19 | 327 |
GO:0007030 | Golgi organization | 5.62e-02 | 1.00e+00 | 4.114 | 1 | 3 | 49 |
GO:0030900 | forebrain development | 5.62e-02 | 1.00e+00 | 4.114 | 1 | 1 | 49 |
GO:0006521 | regulation of cellular amino acid metabolic process | 5.74e-02 | 1.00e+00 | 4.085 | 1 | 1 | 50 |
GO:0030175 | filopodium | 5.74e-02 | 1.00e+00 | 4.085 | 1 | 1 | 50 |
GO:0030334 | regulation of cell migration | 5.74e-02 | 1.00e+00 | 4.085 | 1 | 5 | 50 |
GO:0000910 | cytokinesis | 5.85e-02 | 1.00e+00 | 4.056 | 1 | 2 | 51 |
GO:0000226 | microtubule cytoskeleton organization | 5.96e-02 | 1.00e+00 | 4.028 | 1 | 2 | 52 |
GO:0009611 | response to wounding | 5.96e-02 | 1.00e+00 | 4.028 | 1 | 5 | 52 |
GO:0003723 | RNA binding | 6.03e-02 | 1.00e+00 | 2.311 | 2 | 18 | 342 |
GO:0032851 | positive regulation of Rab GTPase activity | 6.07e-02 | 1.00e+00 | 4.001 | 1 | 2 | 53 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 6.07e-02 | 1.00e+00 | 4.001 | 1 | 5 | 53 |
GO:0015758 | glucose transport | 6.29e-02 | 1.00e+00 | 3.947 | 1 | 4 | 55 |
GO:0046330 | positive regulation of JNK cascade | 6.29e-02 | 1.00e+00 | 3.947 | 1 | 2 | 55 |
GO:0000724 | double-strand break repair via homologous recombination | 6.29e-02 | 1.00e+00 | 3.947 | 1 | 2 | 55 |
GO:0007018 | microtubule-based movement | 6.51e-02 | 1.00e+00 | 3.896 | 1 | 1 | 57 |
GO:0008203 | cholesterol metabolic process | 6.51e-02 | 1.00e+00 | 3.896 | 1 | 2 | 57 |
GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 6.73e-02 | 1.00e+00 | 3.846 | 1 | 2 | 59 |
GO:0006396 | RNA processing | 6.73e-02 | 1.00e+00 | 3.846 | 1 | 5 | 59 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 6.73e-02 | 1.00e+00 | 3.846 | 1 | 6 | 59 |
GO:0005925 | focal adhesion | 6.80e-02 | 1.00e+00 | 2.213 | 2 | 9 | 366 |
GO:0008013 | beta-catenin binding | 6.85e-02 | 1.00e+00 | 3.822 | 1 | 9 | 60 |
GO:0060333 | interferon-gamma-mediated signaling pathway | 7.07e-02 | 1.00e+00 | 3.774 | 1 | 3 | 62 |
GO:0030141 | secretory granule | 7.07e-02 | 1.00e+00 | 3.774 | 1 | 4 | 62 |
GO:0004867 | serine-type endopeptidase inhibitor activity | 7.18e-02 | 1.00e+00 | 3.751 | 1 | 3 | 63 |
GO:0000776 | kinetochore | 7.18e-02 | 1.00e+00 | 3.751 | 1 | 5 | 63 |
GO:0045666 | positive regulation of neuron differentiation | 7.18e-02 | 1.00e+00 | 3.751 | 1 | 3 | 63 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 7.29e-02 | 1.00e+00 | 3.729 | 1 | 1 | 64 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 7.40e-02 | 1.00e+00 | 3.706 | 1 | 2 | 65 |
GO:0031295 | T cell costimulation | 7.40e-02 | 1.00e+00 | 3.706 | 1 | 1 | 65 |
GO:0035264 | multicellular organism growth | 7.61e-02 | 1.00e+00 | 3.663 | 1 | 2 | 67 |
GO:0000278 | mitotic cell cycle | 7.63e-02 | 1.00e+00 | 2.118 | 2 | 15 | 391 |
GO:0010468 | regulation of gene expression | 7.72e-02 | 1.00e+00 | 3.641 | 1 | 2 | 68 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 7.94e-02 | 1.00e+00 | 3.599 | 1 | 2 | 70 |
GO:0005085 | guanyl-nucleotide exchange factor activity | 8.05e-02 | 1.00e+00 | 3.579 | 1 | 5 | 71 |
GO:0007626 | locomotory behavior | 8.05e-02 | 1.00e+00 | 3.579 | 1 | 2 | 71 |
GO:0060021 | palate development | 8.16e-02 | 1.00e+00 | 3.559 | 1 | 1 | 72 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 8.16e-02 | 1.00e+00 | 3.559 | 1 | 1 | 72 |
GO:0003729 | mRNA binding | 8.16e-02 | 1.00e+00 | 3.559 | 1 | 4 | 72 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 8.38e-02 | 1.00e+00 | 3.519 | 1 | 2 | 74 |
GO:0001843 | neural tube closure | 8.38e-02 | 1.00e+00 | 3.519 | 1 | 2 | 74 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 8.38e-02 | 1.00e+00 | 3.519 | 1 | 4 | 74 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 8.38e-02 | 1.00e+00 | 3.519 | 1 | 2 | 74 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 8.49e-02 | 1.00e+00 | 3.500 | 1 | 1 | 75 |
GO:0010629 | negative regulation of gene expression | 8.70e-02 | 1.00e+00 | 3.462 | 1 | 4 | 77 |
GO:0043066 | negative regulation of apoptotic process | 8.77e-02 | 1.00e+00 | 2.001 | 2 | 16 | 424 |
GO:0071013 | catalytic step 2 spliceosome | 8.81e-02 | 1.00e+00 | 3.443 | 1 | 7 | 78 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 8.92e-02 | 1.00e+00 | 3.425 | 1 | 2 | 79 |
GO:0045177 | apical part of cell | 9.13e-02 | 1.00e+00 | 3.389 | 1 | 3 | 81 |
GO:0009653 | anatomical structure morphogenesis | 9.35e-02 | 1.00e+00 | 3.354 | 1 | 2 | 83 |
GO:0007596 | blood coagulation | 9.89e-02 | 1.00e+00 | 1.899 | 2 | 11 | 455 |
GO:0016605 | PML body | 9.89e-02 | 1.00e+00 | 3.269 | 1 | 3 | 88 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 1.03e-01 | 1.00e+00 | 3.205 | 1 | 1 | 92 |
GO:0001649 | osteoblast differentiation | 1.03e-01 | 1.00e+00 | 3.205 | 1 | 5 | 92 |
GO:0030165 | PDZ domain binding | 1.05e-01 | 1.00e+00 | 3.174 | 1 | 1 | 94 |
GO:0042802 | identical protein binding | 1.10e-01 | 1.00e+00 | 1.810 | 2 | 19 | 484 |
GO:0006805 | xenobiotic metabolic process | 1.15e-01 | 1.00e+00 | 3.042 | 1 | 2 | 103 |
GO:0010951 | negative regulation of endopeptidase activity | 1.16e-01 | 1.00e+00 | 3.028 | 1 | 6 | 104 |
GO:0005938 | cell cortex | 1.16e-01 | 1.00e+00 | 3.028 | 1 | 5 | 104 |
GO:0005730 | nucleolus | 1.19e-01 | 1.00e+00 | 1.048 | 4 | 66 | 1641 |
GO:0003676 | nucleic acid binding | 1.19e-01 | 1.00e+00 | 2.987 | 1 | 2 | 107 |
GO:0005815 | microtubule organizing center | 1.21e-01 | 1.00e+00 | 2.960 | 1 | 3 | 109 |
GO:0030529 | ribonucleoprotein complex | 1.24e-01 | 1.00e+00 | 2.921 | 1 | 5 | 112 |
GO:0005635 | nuclear envelope | 1.25e-01 | 1.00e+00 | 2.908 | 1 | 5 | 113 |
GO:0048015 | phosphatidylinositol-mediated signaling | 1.26e-01 | 1.00e+00 | 2.896 | 1 | 2 | 114 |
GO:0000209 | protein polyubiquitination | 1.28e-01 | 1.00e+00 | 2.871 | 1 | 3 | 116 |
GO:0008201 | heparin binding | 1.35e-01 | 1.00e+00 | 2.798 | 1 | 1 | 122 |
GO:0030027 | lamellipodium | 1.38e-01 | 1.00e+00 | 2.763 | 1 | 7 | 125 |
GO:0070062 | extracellular vesicular exosome | 1.39e-01 | 1.00e+00 | 0.822 | 5 | 57 | 2400 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 1.41e-01 | 1.00e+00 | 2.729 | 1 | 11 | 128 |
GO:0005215 | transporter activity | 1.43e-01 | 1.00e+00 | 2.706 | 1 | 3 | 130 |
GO:0005911 | cell-cell junction | 1.49e-01 | 1.00e+00 | 2.641 | 1 | 2 | 136 |
GO:0045202 | synapse | 1.49e-01 | 1.00e+00 | 2.641 | 1 | 5 | 136 |
GO:0007507 | heart development | 1.52e-01 | 1.00e+00 | 2.610 | 1 | 7 | 139 |
GO:0005829 | cytosol | 1.57e-01 | 1.00e+00 | 0.765 | 5 | 86 | 2496 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 1.58e-01 | 1.00e+00 | 2.549 | 1 | 4 | 145 |
GO:0010628 | positive regulation of gene expression | 1.59e-01 | 1.00e+00 | 2.539 | 1 | 7 | 146 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.62e-01 | 1.00e+00 | 2.509 | 1 | 3 | 149 |
GO:0042981 | regulation of apoptotic process | 1.63e-01 | 1.00e+00 | 2.500 | 1 | 4 | 150 |
GO:0006974 | cellular response to DNA damage stimulus | 1.64e-01 | 1.00e+00 | 2.490 | 1 | 7 | 151 |
GO:0044281 | small molecule metabolic process | 1.67e-01 | 1.00e+00 | 1.072 | 3 | 20 | 1211 |
GO:0043005 | neuron projection | 1.70e-01 | 1.00e+00 | 2.434 | 1 | 3 | 157 |
GO:0046777 | protein autophosphorylation | 1.71e-01 | 1.00e+00 | 2.425 | 1 | 4 | 158 |
GO:0008022 | protein C-terminus binding | 1.74e-01 | 1.00e+00 | 2.398 | 1 | 8 | 161 |
GO:0043687 | post-translational protein modification | 1.75e-01 | 1.00e+00 | 2.389 | 1 | 5 | 162 |
GO:0000398 | mRNA splicing, via spliceosome | 1.77e-01 | 1.00e+00 | 2.371 | 1 | 15 | 164 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.84e-01 | 1.00e+00 | 2.311 | 1 | 2 | 171 |
GO:0005667 | transcription factor complex | 1.88e-01 | 1.00e+00 | 2.277 | 1 | 17 | 175 |
GO:0004672 | protein kinase activity | 1.89e-01 | 1.00e+00 | 2.261 | 1 | 3 | 177 |
GO:0003714 | transcription corepressor activity | 1.90e-01 | 1.00e+00 | 2.253 | 1 | 11 | 178 |
GO:0019904 | protein domain specific binding | 1.91e-01 | 1.00e+00 | 2.245 | 1 | 8 | 179 |
GO:0005524 | ATP binding | 1.93e-01 | 1.00e+00 | 0.972 | 3 | 31 | 1298 |
GO:0004872 | receptor activity | 2.01e-01 | 1.00e+00 | 2.166 | 1 | 8 | 189 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 2.01e-01 | 1.00e+00 | 2.166 | 1 | 5 | 189 |
GO:0030168 | platelet activation | 2.16e-01 | 1.00e+00 | 2.049 | 1 | 6 | 205 |
GO:0016071 | mRNA metabolic process | 2.33e-01 | 1.00e+00 | 1.928 | 1 | 8 | 223 |
GO:0007067 | mitotic nuclear division | 2.36e-01 | 1.00e+00 | 1.902 | 1 | 6 | 227 |
GO:0005759 | mitochondrial matrix | 2.37e-01 | 1.00e+00 | 1.896 | 1 | 4 | 228 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 2.38e-01 | 1.00e+00 | 1.105 | 2 | 41 | 789 |
GO:0030425 | dendrite | 2.39e-01 | 1.00e+00 | 1.883 | 1 | 6 | 230 |
GO:0043025 | neuronal cell body | 2.53e-01 | 1.00e+00 | 1.792 | 1 | 9 | 245 |
GO:0016070 | RNA metabolic process | 2.55e-01 | 1.00e+00 | 1.780 | 1 | 8 | 247 |
GO:0005975 | carbohydrate metabolic process | 2.60e-01 | 1.00e+00 | 1.746 | 1 | 8 | 253 |
GO:0006281 | DNA repair | 2.67e-01 | 1.00e+00 | 1.701 | 1 | 14 | 261 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 2.74e-01 | 1.00e+00 | 1.657 | 1 | 7 | 269 |
GO:0030198 | extracellular matrix organization | 2.86e-01 | 1.00e+00 | 1.584 | 1 | 6 | 283 |
GO:0007186 | G-protein coupled receptor signaling pathway | 2.91e-01 | 1.00e+00 | 1.554 | 1 | 1 | 289 |
GO:0005856 | cytoskeleton | 2.93e-01 | 1.00e+00 | 1.544 | 1 | 9 | 291 |
GO:0019901 | protein kinase binding | 3.15e-01 | 1.00e+00 | 1.420 | 1 | 18 | 317 |
GO:0008283 | cell proliferation | 3.24e-01 | 1.00e+00 | 1.371 | 1 | 14 | 328 |
GO:0030054 | cell junction | 3.30e-01 | 1.00e+00 | 1.336 | 1 | 5 | 336 |
GO:0006355 | regulation of transcription, DNA-templated | 3.31e-01 | 1.00e+00 | 0.767 | 2 | 43 | 997 |
GO:0043565 | sequence-specific DNA binding | 3.38e-01 | 1.00e+00 | 1.294 | 1 | 11 | 346 |
GO:0000139 | Golgi membrane | 3.50e-01 | 1.00e+00 | 1.233 | 1 | 7 | 361 |
GO:0005886 | plasma membrane | 3.63e-01 | 1.00e+00 | 0.394 | 4 | 49 | 2582 |
GO:0009986 | cell surface | 3.82e-01 | 1.00e+00 | 1.078 | 1 | 9 | 402 |
GO:0045892 | negative regulation of transcription, DNA-templated | 3.90e-01 | 1.00e+00 | 1.039 | 1 | 24 | 413 |
GO:0006366 | transcription from RNA polymerase II promoter | 3.94e-01 | 1.00e+00 | 1.018 | 1 | 30 | 419 |
GO:0055085 | transmembrane transport | 4.06e-01 | 1.00e+00 | 0.964 | 1 | 8 | 435 |
GO:0044267 | cellular protein metabolic process | 4.34e-01 | 1.00e+00 | 0.840 | 1 | 20 | 474 |
GO:0045893 | positive regulation of transcription, DNA-templated | 4.36e-01 | 1.00e+00 | 0.828 | 1 | 24 | 478 |
GO:0005737 | cytoplasm | 4.69e-01 | 1.00e+00 | 0.171 | 5 | 124 | 3767 |
GO:0006915 | apoptotic process | 4.87e-01 | 1.00e+00 | 0.612 | 1 | 12 | 555 |
GO:0005783 | endoplasmic reticulum | 4.88e-01 | 1.00e+00 | 0.610 | 1 | 13 | 556 |
GO:0005789 | endoplasmic reticulum membrane | 4.96e-01 | 1.00e+00 | 0.574 | 1 | 9 | 570 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 4.96e-01 | 1.00e+00 | 0.574 | 1 | 37 | 570 |
GO:0042803 | protein homodimerization activity | 5.12e-01 | 1.00e+00 | 0.512 | 1 | 19 | 595 |
GO:0045087 | innate immune response | 5.12e-01 | 1.00e+00 | 0.509 | 1 | 15 | 596 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 5.70e-01 | 1.00e+00 | 0.279 | 1 | 39 | 699 |
GO:0005887 | integral component of plasma membrane | 6.61e-01 | 1.00e+00 | -0.066 | 1 | 10 | 888 |
GO:0016021 | integral component of membrane | 7.00e-01 | 1.00e+00 | -0.224 | 2 | 17 | 1982 |
GO:0046872 | metal ion binding | 8.01e-01 | 1.00e+00 | -0.623 | 1 | 29 | 1307 |